Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic
- 6 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 181 (5) , 946-953
Abstract
Clinical question Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis (PsA) in obese individuals? Background Obesity presents a rising public health challenge and is more prevalent amongst individuals with psoriasis or PsA compared to the general population. Longitudinal population‐based studies suggest a causal role for obesity in psoriasis and PsA onset and that obesity drives greater disease severity. Methods We systematically reviewed evidence within Medline/EMBASE/CENTRAL databases and clinical trials registries examining lifestyle, pharmacological and surgical weight loss interventions in the treatment and prevention of psoriasis and PsA in obese individuals. Meta‐analysis was conducted using random effects models, followed by sensitivity analyses. Results Of 176 full‐text articles reviewed, 14 met the inclusion criteria. Meta‐analysis of six randomised control trials (RCTs) confirmed that weight loss following lifestyle interventions (diet/physical activity) improves psoriasis compared to control (mean change in psoriasis area and severity index ‐2·59; 95%CI ‐4·09, ‐1·09; p<0·001). One RCT demonstrated a greater likelihood of achieving minimal PsA activity following diet‐induced weight loss (odds ratio 4·20; 95%CI 1·82‐9·66; p<0·001). Three studies of pharmacological treatments reported conflicting results and no RCTs of bariatric surgery were identified. Two cohort studies suggested bariatric surgery, particularly gastric bypass, reduces the risk of developing psoriasis (hazard ratio 0·52; 95%CI 0·33‐0·81; p<0·01). Discussion/recommendation These limited data indicate that weight loss can improve pre‐existing psoriasis and PsA, and prevent the onset of psoriasis in obese individuals. Together with NICE obesity guidance, this informed a local obesity screening and management pathway, providing multi‐disciplinary weight loss interventions alongside conventional skin‐focused care for psoriasis.Keywords
Funding Information
- National Institute for Health Research
This publication has 60 references indexed in Scilit:
- The association between psoriasis and obesity: a systematic review and meta-analysis of observational studiesNutrition & Diabetes, 2012
- The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of diseaseNature Reviews Immunology, 2011
- Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasisDiabetologia, 2011
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Definition of treatment goals for moderate to severe psoriasis: a European consensusArchives of Dermatological Research, 2010
- Regulatory activity of polyunsaturated fatty acids in T-cell signalingProgress in Lipid Research, 2010
- Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatmentAnnals of the Rheumatic Diseases, 2010
- British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009British Journal of Dermatology, 2009
- Trends in incidence of adult-onset psoriasis over three decades: A population-based studyJournal of the American Academy of Dermatology, 2009
- Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesityClinical and Experimental Dermatology, 2009